Imbio PHA (4.0.0) vs Clarius AI
AI Verdict
Choose Imbio PHA (4.0.0) if…
Choose Imbio PHA (4.0.0) if your primary need is automated, precise analysis of *existing CT pulmonary angiogram (CTPA) scans*. This tool excels at rapidly measuring cardiac structures like RV/LV and PA/Ao ratios to aid in the diagnosis and risk stratification of pulmonary embolism and hypertension, transforming static images into actionable insights.
View Imbio PHA (4.0.0) →Choose Clarius AI if…
Choose Clarius AI if you require a highly portable, real-time ultrasound solution with integrated AI for immediate imaging and guidance *at the point of care*. It is ideal for clinicians across various specialties who need automated image optimization, real-time anatomical labeling, and semi-automatic measurements directly from a handheld device during live scans.
View Clarius AI →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Imbio PHA (4.0.0) | Clarius AI |
|---|---|---|
| Deployment | Cloud (AWS) or On-premise (VMware) or via partners (Nuance, Aidoc, Siemens Syngo.via, TeraRecon, FerrumHealth, Flywheel). | Cloud, Mobile App |
| FDA Status | Yes AI-estimated | Unknown |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Clarius AIClarius AI is integrated into handheld ultrasound scanners with real-time AI labeling, anatomical overlays, and voice controls, offering a highly interactive and user-friendly experience at the point of care. Imbio PHA, while integrating with existing DICOM workflows, focuses more on automated post-acquisition analysis rather than real-time interactive use during image capture.
Clinical Value
Imbio PHA (4.0.0)Imbio PHA provides automated, quantitative measurements from CTPA scans to aid in the diagnosis and risk stratification of pulmonary embolism and hypertension, addressing a critical clinical need with direct impact on patient management. Clarius AI offers broader enhancements for ultrasound image quality and measurements across specialties, but Imbio PHA's specific application for life-threatening conditions provides a more focused and high-impact clinical decision support.
Pricing & Value
Clarius AIClarius AI offers transparent pricing with clear options for scanner purchase and annual membership, detailing the features unlocked, including AI tools and cloud storage. Imbio PHA's pricing is only available upon contact, making it difficult to assess its value proposition without further inquiry.
Enterprise Readiness
Imbio PHA (4.0.0)Imbio PHA explicitly supports 'Enterprise (on-premise)' deployment and integrates deeply with native DICOM tools and workflows, which are crucial for large-scale hospital system integration. While Clarius AI offers DICOM/PACS integration, its primary deployment via mobile apps and handheld devices may present different challenges for centralized enterprise management compared to Imbio PHA's more traditional enterprise deployment options.
Innovation
Clarius AIClarius AI demonstrates significant innovation by integrating AI directly into wireless, ultra-portable handheld ultrasound scanners, offering real-time guidance, anatomical overlays, and voice controls. This approach makes advanced ultrasound more accessible and user-friendly at the point of care. Imbio PHA's innovation lies in automated quantitative analysis of existing CT data, which is valuable but less disruptive to the imaging workflow than Clarius AI's real-time, portable solution.
Support & Docs
Clarius AIClarius AI explicitly mentions 'access to the Clarius Education Portal' as a benefit of its membership, indicating structured resources for user support and learning. Imbio PHA's provided information does not detail any specific support or documentation resources, making it impossible to assess this dimension for Tool A.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Imbio PHA (4.0.0) | Clarius AI |
|---|---|---|
| Product Name | Imbio PHA (4.0.0) | Clarius AI |
| Company | Imbio | Clarius Mobile Health |
| Primary Function | AI-powered medical image processing software that automatically measures cardiac structures from CT pulmonary angiogram (CTPA) scans to assess potential right ventricular dilation and aid in the diagnosis and risk stratification of pulmonary embolism and hypertension. | Suite of artificial intelligence features integrated into Clarius Mobile Health's handheld ultrasound scanners and app, designed to enhance image quality, automate measurements, and provide real-time guidance for clinicians across various specialties. |
| Categories | Cardiology AI, Radiology & Imaging AI | Cardiology AI, OB/GYN AI, Radiology & Imaging AI |
| Specialties | Cardiology, Pulmonology, Radiology | Emergency Medicine, Obstetrics & Gynecology, Radiology |
| Key Features (Examples) | Automated measurement of right and left ventricle diameters; Calculates RV/LV and PA/Ao ratios; Generates annotated DICOM images; Rapid, fully-automated assessment (typically in minutes) | Auto Preset AI for automatic image optimization and anatomy detection; Real-time AI labeling and anatomical overlays; Semi-automatic measurements for various structures; Wireless and ultra-portable handheld ultrasound scanners |
Videos
Demos, reviews, and walkthroughs featuring Imbio PHA (4.0.0) and Clarius AI.